Doctronic raises US$40 million in Series B financing
On March 24, 2026, Doctronic Inc. (“Doctronic”) announced a US$40 million Series B round co-led by Abstract and Lightspeed Venture Partners, with participation from investors including Union Square Ventures, Seven Stars, Mantis, Tusk Ventures and Wittington Ventures.
The Series B will expand partnerships with hospital systems, academic institutions, digital health platforms, and payers. It will also fund expansion into pediatrics, where consumer demand far outpaces access.
Further information can be found on Business Wire’s website.
Doctronic is the first AI system legally authorized to practice medicine autonomously in the United States. Built on a collective intelligence architecture, it provides free personalized health insights and connects users to licensed providers instantly, affordably, and securely.
Abstract is a venture capital firm investing in transformative technology companies. The firm partners with founders building category-defining businesses across AI, infrastructure, and frontier technologies.
Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations in AI, Enterprise, Consumer, Health, and Fintech.
Wittington Ventures is a multi-stage investment platform that backs transformative companies across the consumer, commerce, healthcare, and climate sectors.